5-Benzyl L-glutamate N-carboxyanhydride

We are 5-Benzyl L-glutamate N-carboxyanhydride CAS:3190-71-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:5-Benzyl L-glutamate N-carboxyanhydride
CAS.NO:3190-71-4
Synonyms:5-Benzyl L-glutamate N-carboxyanhydride
benzyl 3-[(4S)-2,5-dioxo-1,3-oxazolidin-4-yl]propanoate
Glu(OBzl)NCA
L-Glu(Obzl)-NCA
 
Physical and Chemical Properties:
Density 1.293
Melting Point 97-98 ºC
Molecular Formula C13H13NO5
Molecular Weight 263.246
Index of Refraction 1.540
 
Specification:
Appearance:White to off-white powder
Assay(HPLC):≥98.0%
Melting Point:85-95ºC
Specific rotation:-16~-12º
Moisture:≤1.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Glatiramer acetate(CAS:147245-92-9).

5-Benzyl L-glutamate N-carboxyanhydride


Related News: With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.1-clorotetradecano CAS:2425-54-9 With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.3-metil-1-butanotiol CAS:541-31-1 The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself.4- [2- [2- (4-aminofenoxi) etil-metilamino] etil] anilina CAS:115256-13-8 The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself.Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely.

Related Products
Product Name
1-IODO-4,4,4-TRIFLUOROBUTANE View Details
Ethyl (1E)-N-cyanoethanimidate View Details
3-Bromo-4-isobutoxybenzothioamide View Details
3,5-DI-O-(P-TOLUYL)-2-DEOXY-D-RIBOFURANOSYL CHLORIDE manufacturer (4R,5R)-3-oxo-2-oxabicyclo[2.2.1]heptane-5-carboxylic acid manufacturer Biotinyl-GHK tripeptide manufacturer 2-Chloro-5-hydroxymethylpyridine manufacturer 2-((4-Methyl-2-nitrophenyl)amino)ethanol manufacturer